Detalhe da pesquisa
1.
An update on the immune landscape in lung and head and neck cancers.
CA Cancer J Clin;
70(6): 505-517, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32841388
2.
Characteristics and anatomic location of PD-1+TCF1+ stem-like CD8 T cells in chronic viral infection and cancer.
Proc Natl Acad Sci U S A;
120(41): e2221985120, 2023 10 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37782797
3.
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells.
Nature;
576(7787): 465-470, 2019 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31827286
4.
Advancing immunotherapy in small cell lung cancer.
Cancer;
129(22): 3525-3534, 2023 11 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37602492
5.
Safety and efficacy of durvalumab after concurrent chemoradiation in Black patients with locally advanced non-small cell lung cancer.
Cancer;
129(23): 3713-3723, 2023 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37354070
6.
Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.
Oncologist;
28(12): 1055-1063, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37418599
7.
Role of osimertinib in the treatment of EGFR-mutation positive non-small-cell lung cancer.
Future Oncol;
15(8): 805-816, 2019 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30657347
8.
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
J Immunother Cancer;
12(3)2024 Mar 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38531662
9.
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience.
JTO Clin Res Rep;
3(6): 100328, 2022 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35637759
10.
Impact of radiation dose to the immune cells in unresectable or stage III non-small cell lung cancer in the durvalumab era.
Radiother Oncol;
174: 133-140, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35870727
11.
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Proteolysis-Targeting Chimeras: The Pharmacology of Cutting-Edge Lung Cancer Therapies.
Am Soc Clin Oncol Educ Book;
41: e286-e293, 2021 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34061559
12.
Integrating Genetic and Genomic Testing Into Oncology Practice.
Am Soc Clin Oncol Educ Book;
40: e259-e263, 2020 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32453613
13.
The prospects for combination therapy with capecitabine in the rapidly evolving treatment landscape of renal cell carcinoma.
Expert Opin Investig Drugs;
27(2): 163-170, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29323560
14.
Considerations for cancer immunotherapy biomarker research during COVID-19.
Endocr Relat Cancer;
27(9): C1-C8, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32508308
15.
Improving outcomes for brain metastases in EGFR mutated NSCLC.
Transl Lung Cancer Res;
8(Suppl 4): S355-S359, 2019 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32038914
16.
A banner year for immunotherapy and targeted therapy.
Nat Rev Clin Oncol;
16(2): 79-80, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30538305